Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,300 peer-reviewed publications.

The CPRD bibliography is updated on a monthly basis (last updated 4 December 2019) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

(PDF, 3MB, 193 pages)

 

Export 4 results:
[ Author(Desc)] Title Type Year
Filters: Author is Weng, S. F.  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
W
S. F. Weng, Kai, J., H. Neil, A., Humphries, S. E., and Qureshi, N., “Improving identification of familial hypercholesterolaemia in primary care: derivation and validation of the familial hypercholesterolaemia case ascertainment tool (FAMCAT)”, Atherosclerosis, vol. 238, pp. 336-43, 2015.
S. F. Weng, Kai, J., Guha, I. N., and Qureshi, N., “The value of aspartate aminotransferase and alanine aminotransferase in cardiovascular disease risk assessment”, Open Heart, vol. 2, p. e000272, 2015.
S. F. Weng, Reps, J., Kai, J., Garibaldi, J. M., and Qureshi, N., “Can machine-learning improve cardiovascular risk prediction using routine clinical data?”, PLoS One, vol. 12, p. e0174944, 2017.
S. F. Weng, Vaz, L., Qureshi, N., and Kai, J., “Prediction of premature all-cause mortality: A prospective general population cohort study comparing machine-learning and standard epidemiological approaches”, PLoS One, vol. 14, p. e0214365, 2019.
[Page last reviewed 6 December 2019]